Physician profile
Meredith Lyn Langhorst
NPI 1487606034
$232,788.14
in general payments reported to CMS, 2019-2025
10 companies · $40K in 2025
The $40K reported for 2025 was more than what 98% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $121 · 2021: $13K · 2022: $105K · 2023: $16K · 2024: $59K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $50K · Consulting Fee: $44K · Travel and Lodging: $14K · Food and Beverage: $6,696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $49,565.00 |
| Consulting Fee | $44,195.28 |
| Travel and Lodging | $14,050.01 |
| Food and Beverage | $6,696.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $228,792.18 | 2021-2025 | Reactiv8 |
| Boston Scientific Corporation | $2,975.41 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Abbott Laboratories | $479.44 | 2022-2024 | Eterna |
| Si-Bone, INC. | $138.31 | 2021 | |
| Relievant Medsystems, INC. | $121.03 | 2020 | |
| Stimwave Technologies Incorporated | $116.99 | 2022 | |
| Spr Therapeutics, INC | $108.77 | 2022-2024 | Sprint Pns System |
| Medtronic, INC. | $35.00 | 2021 | |
| Saluda Medical Americas, INC. | $21.01 | 2024 | Evoke |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Langhorst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.